Search Results 821-830 of 21580 for Inhibition
Analgesic drugs including NSAIDs and COX-2 inhibitors. NOTE: Stable doses of thyroid replacement, estrogen replacement, low-dose aspirin for ...
Prior history of receiving pazopanib or any other tyrosine kinase inhibitor ... Use of strong or moderate inhibitors are prohibited ≤ 7 days prior to ...
Developing a new drug for women with resistance to aromatase inhibitors; Identifying mechanisms for why some people do not respond to endocrine treatment ...
combined (estrogen or progestogen containing) hormonal contraception associated with the inhibition of ovulation (either oral, intravaginal, or transdermal); ...
Kinase inhibitors such as midostaurin. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date ...
If melanoma is BRAF wild-type or has BRAF mutations that are not amenable to BRAF inhibitor therapy, and the patient is a candidate for immunotherapy, must ...
guidance for patients in transplant trials (Refer to Manual of Procedures). 9. Triple Immunosuppression - Calcineurin Inhibitor/Mycophenolic Acid/Steroid
For Arm C only: Have received at least one prior therapy, relapsed or refractory WM and naïve to BTK inhibitor therapy. 6. For Arm E only: Have received at ...
DeVault has been involved in the study of all proton pump inhibitors dating back to omeprazole and most recently the potassium competitive acid blockers.
Known history of factor IX inhibitors; Inhibitors to factor IX (above or equal to 0.6 BU) at screening measured by the Nijmegen modified Bethesda method ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.